Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 17, 2020 08:30 ET | Source: Yield10 Bioscience, Inc.

Yield10 Bioscience Obtains Positive Response from USDA-APHIS on Regulated Status of its CRISPR Genome-Edited C3007 Trait in Canola; Plans U.S. Field Tests for 2021

WOBURN, Mass., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has obtained a positive response from...
August 11, 2020 16:05 ET | Source: Yield10 Bioscience, Inc.

Yield10 Bioscience Announces Second Quarter 2020 Financial Results

WOBURN, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and six months ended June...
May 14, 2020 16:15 ET | Source: Yield10 Bioscience, Inc.

Yield10 Bioscience Announces First Quarter 2020 Financial Results

WOBURN, Mass., May 14, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three months ended March 31,...
May 14, 2020 16:10 ET | Source: Yield10 Bioscience, Inc.

Yield10 Bioscience Secures Regulatory Permits for U.S. and Canadian Sites and Announces Plans for 2020 Field Test Program in Camelina and Canola

WOBURN, Mass., May 14, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company has secured all of the regulatory permits...
April 27, 2020 08:30 ET | Source: Yield10 Bioscience, Inc.

Yield10 Bioscience Obtains Positive Response from USDA-APHIS on Regulatory Status of its CRISPR Genome-Edited C3007 Trait in Camelina, Paving the Way for U.S. Field Tests

WOBURN, Mass., April 27, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has obtained a positive response from...
March 19, 2020 16:04 ET | Source: Yield10 Bioscience, Inc.

Yield10 Bioscience Announces Fourth Quarter and Full Year 2019 Financial Results

WOBURN, Mass., March 19, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and twelve months ended...
March 19, 2020 16:02 ET | Source: Yield10 Bioscience, Inc.

Yield10 Bioscience Announces Results of 2019 Field Test Program

-- 2019 Field Test Results Highlight CRISPR Technology Approach to Increase in Oil Content in Oilseed Crops -- Outlines Field Tests Planned for 2020 WOBURN, Mass., March 19, 2020 (GLOBE NEWSWIRE)...
January 16, 2020 08:30 ET | Source: Yield10 Bioscience, Inc.

Yield10 Bioscience Submits "Am I Regulated?" Letter to USDA-APHIS BRS for CRISPR Genome-Edited C3007 in Camelina to Pave the Way for U.S. Field Tests

WOBURN, Mass., Jan. 16, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the...
May 08, 2019 08:30 ET | Source: Yield10 Bioscience, Inc.

Yield10 Bioscience Signs Exclusive Worldwide License with University of Missouri for Advanced Technology Used to Boost Oil Content in Crops

WOBURN, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the...
October 02, 2018 08:00 ET | Source: Yield10 Bioscience, Inc.

Yield10 Bioscience Obtains Nonregulated Status for its Novel CRISPR-Cas9 Triple Gene Edited Camelina Plant Lines to Boost Seed Oil Content

--USDA-APHIS Response Marks Clearance of Yield10’s First Triple Genome-edited Plant Lines --Favorable Response Accelerates Path to U.S. Field Trials in 2019 WOBURN, Mass., Oct. 02, 2018 (GLOBE...

Next Page keyboard_arrow_right